nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B3—Levothyroxine—hypothyroidism	0.162	0.183	CbGbCtD
Olmesartan—SLCO1B3—Liothyronine—hypothyroidism	0.162	0.183	CbGbCtD
Olmesartan—SLCO1B3—Liotrix—hypothyroidism	0.158	0.178	CbGbCtD
Olmesartan—SLCO1B1—Dextrothyroxine—hypothyroidism	0.124	0.14	CbGbCtD
Olmesartan—SLCO1B1—Liothyronine—hypothyroidism	0.0942	0.106	CbGbCtD
Olmesartan—SLCO1B1—Levothyroxine—hypothyroidism	0.0942	0.106	CbGbCtD
Olmesartan—SLCO1B1—Liotrix—hypothyroidism	0.0919	0.104	CbGbCtD
Olmesartan—Acute bronchitis—Liotrix—hypothyroidism	0.00593	0.065	CcSEcCtD
Olmesartan—Tracheobronchitis—Liotrix—hypothyroidism	0.00513	0.0561	CcSEcCtD
Olmesartan—Gastric irritation—Liotrix—hypothyroidism	0.00399	0.0437	CcSEcCtD
Olmesartan—Epigastric discomfort—Liotrix—hypothyroidism	0.00294	0.0322	CcSEcCtD
Olmesartan—Angina pectoris—Liothyronine—hypothyroidism	0.00262	0.0287	CcSEcCtD
Olmesartan—Arrhythmia—Liothyronine—hypothyroidism	0.00192	0.0211	CcSEcCtD
Olmesartan—Tachycardia—Liothyronine—hypothyroidism	0.00149	0.0163	CcSEcCtD
Olmesartan—Blood urea increased—Liotrix—hypothyroidism	0.00146	0.016	CcSEcCtD
Olmesartan—Hypotension—Liothyronine—hypothyroidism	0.00143	0.0156	CcSEcCtD
Olmesartan—SLCO1B3—pituitary gland—hypothyroidism	0.00139	0.108	CbGeAlD
Olmesartan—Lightheadedness—Liotrix—hypothyroidism	0.00139	0.0152	CcSEcCtD
Olmesartan—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00129	0.0141	CcSEcCtD
Olmesartan—Angina pectoris—Levothyroxine—hypothyroidism	0.00129	0.0141	CcSEcCtD
Olmesartan—Renal failure acute—Liotrix—hypothyroidism	0.00122	0.0133	CcSEcCtD
Olmesartan—Body temperature increased—Liothyronine—hypothyroidism	0.00121	0.0132	CcSEcCtD
Olmesartan—Blood creatinine increased—Liotrix—hypothyroidism	0.00105	0.0115	CcSEcCtD
Olmesartan—AGTR1—adrenal cortex—hypothyroidism	0.00105	0.0809	CbGeAlD
Olmesartan—Hypokalaemia—Liotrix—hypothyroidism	0.00102	0.0112	CcSEcCtD
Olmesartan—AGTR1—heart—hypothyroidism	0.00101	0.0782	CbGeAlD
Olmesartan—SLCO1B3—liver—hypothyroidism	0.000974	0.0753	CbGeAlD
Olmesartan—AGTR1—cardiovascular system—hypothyroidism	0.000955	0.0738	CbGeAlD
Olmesartan—Angina pectoris—Liotrix—hypothyroidism	0.000946	0.0104	CcSEcCtD
Olmesartan—Arrhythmia—Dextrothyroxine—hypothyroidism	0.000944	0.0103	CcSEcCtD
Olmesartan—Arrhythmia—Levothyroxine—hypothyroidism	0.000944	0.0103	CcSEcCtD
Olmesartan—Bronchitis—Liotrix—hypothyroidism	0.000934	0.0102	CcSEcCtD
Olmesartan—Alopecia—Levothyroxine—hypothyroidism	0.000934	0.0102	CcSEcCtD
Olmesartan—Alopecia—Dextrothyroxine—hypothyroidism	0.000934	0.0102	CcSEcCtD
Olmesartan—SLCO1B3—Transport of organic anions—AVP—hypothyroidism	0.00091	0.094	CbGpPWpGaD
Olmesartan—Renal failure—Liotrix—hypothyroidism	0.000851	0.00932	CcSEcCtD
Olmesartan—Agitation—Dextrothyroxine—hypothyroidism	0.000846	0.00926	CcSEcCtD
Olmesartan—Agitation—Levothyroxine—hypothyroidism	0.000846	0.00926	CcSEcCtD
Olmesartan—AGTR1—pituitary gland—hypothyroidism	0.000846	0.0654	CbGeAlD
Olmesartan—Angioedema—Dextrothyroxine—hypothyroidism	0.000841	0.00921	CcSEcCtD
Olmesartan—Angioedema—Levothyroxine—hypothyroidism	0.000841	0.00921	CcSEcCtD
Olmesartan—Palpitations—Dextrothyroxine—hypothyroidism	0.000813	0.0089	CcSEcCtD
Olmesartan—Palpitations—Levothyroxine—hypothyroidism	0.000813	0.0089	CcSEcCtD
Olmesartan—Arthralgia—Dextrothyroxine—hypothyroidism	0.000783	0.00858	CcSEcCtD
Olmesartan—Arthralgia—Levothyroxine—hypothyroidism	0.000783	0.00858	CcSEcCtD
Olmesartan—Anxiety—Dextrothyroxine—hypothyroidism	0.000781	0.00855	CcSEcCtD
Olmesartan—Anxiety—Levothyroxine—hypothyroidism	0.000781	0.00855	CcSEcCtD
Olmesartan—AGTR1—adrenal gland—hypothyroidism	0.000755	0.0584	CbGeAlD
Olmesartan—AGTR1—blood—hypothyroidism	0.000755	0.0584	CbGeAlD
Olmesartan—Shock—Levothyroxine—hypothyroidism	0.000739	0.00809	CcSEcCtD
Olmesartan—Shock—Dextrothyroxine—hypothyroidism	0.000739	0.00809	CcSEcCtD
Olmesartan—Tachycardia—Levothyroxine—hypothyroidism	0.000733	0.00803	CcSEcCtD
Olmesartan—Tachycardia—Dextrothyroxine—hypothyroidism	0.000733	0.00803	CcSEcCtD
Olmesartan—AGTR1—thyroid gland—hypothyroidism	0.000729	0.0564	CbGeAlD
Olmesartan—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000726	0.00795	CcSEcCtD
Olmesartan—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000726	0.00795	CcSEcCtD
Olmesartan—SLCO1B1—blood—hypothyroidism	0.00072	0.0557	CbGeAlD
Olmesartan—AGTR1—Arf6 trafficking events—CLTC—hypothyroidism	0.000719	0.0742	CbGpPWpGaD
Olmesartan—AGTR1—Arf6 signaling events—TSHR—hypothyroidism	0.000701	0.0724	CbGpPWpGaD
Olmesartan—Arrhythmia—Liotrix—hypothyroidism	0.000695	0.00761	CcSEcCtD
Olmesartan—Alopecia—Liotrix—hypothyroidism	0.000687	0.00752	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000684	0.00749	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000684	0.00749	CcSEcCtD
Olmesartan—Insomnia—Dextrothyroxine—hypothyroidism	0.000679	0.00744	CcSEcCtD
Olmesartan—Insomnia—Levothyroxine—hypothyroidism	0.000679	0.00744	CcSEcCtD
Olmesartan—Fatigue—Dextrothyroxine—hypothyroidism	0.000647	0.00709	CcSEcCtD
Olmesartan—Fatigue—Levothyroxine—hypothyroidism	0.000647	0.00709	CcSEcCtD
Olmesartan—Vision blurred—Liotrix—hypothyroidism	0.000638	0.00699	CcSEcCtD
Olmesartan—AGTR1—testis—hypothyroidism	0.000625	0.0483	CbGeAlD
Olmesartan—Agitation—Liotrix—hypothyroidism	0.000622	0.00681	CcSEcCtD
Olmesartan—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000619	0.00678	CcSEcCtD
Olmesartan—Feeling abnormal—Levothyroxine—hypothyroidism	0.000619	0.00678	CcSEcCtD
Olmesartan—Angioedema—Liotrix—hypothyroidism	0.000618	0.00677	CcSEcCtD
Olmesartan—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000614	0.00672	CcSEcCtD
Olmesartan—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000614	0.00672	CcSEcCtD
Olmesartan—SLCO1B1—Transport of organic anions—AVP—hypothyroidism	0.000611	0.0631	CbGpPWpGaD
Olmesartan—Syncope—Liotrix—hypothyroidism	0.000607	0.00665	CcSEcCtD
Olmesartan—Palpitations—Liotrix—hypothyroidism	0.000598	0.00655	CcSEcCtD
Olmesartan—Urticaria—Levothyroxine—hypothyroidism	0.000597	0.00653	CcSEcCtD
Olmesartan—Urticaria—Dextrothyroxine—hypothyroidism	0.000597	0.00653	CcSEcCtD
Olmesartan—Loss of consciousness—Liotrix—hypothyroidism	0.000595	0.00651	CcSEcCtD
Olmesartan—Abdominal pain—Levothyroxine—hypothyroidism	0.000594	0.0065	CcSEcCtD
Olmesartan—Body temperature increased—Levothyroxine—hypothyroidism	0.000594	0.0065	CcSEcCtD
Olmesartan—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000594	0.0065	CcSEcCtD
Olmesartan—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000594	0.0065	CcSEcCtD
Olmesartan—AGTR1—liver—hypothyroidism	0.000591	0.0457	CbGeAlD
Olmesartan—Chest pain—Liotrix—hypothyroidism	0.000576	0.00631	CcSEcCtD
Olmesartan—Arthralgia—Liotrix—hypothyroidism	0.000576	0.00631	CcSEcCtD
Olmesartan—Anxiety—Liotrix—hypothyroidism	0.000574	0.00629	CcSEcCtD
Olmesartan—SLCO1B1—liver—hypothyroidism	0.000563	0.0435	CbGeAlD
Olmesartan—AGTR1—Arf6 trafficking events—TSHR—hypothyroidism	0.000554	0.0572	CbGpPWpGaD
Olmesartan—Oedema—Liotrix—hypothyroidism	0.000552	0.00605	CcSEcCtD
Olmesartan—Anaphylactic shock—Liotrix—hypothyroidism	0.000552	0.00605	CcSEcCtD
Olmesartan—Infection—Liotrix—hypothyroidism	0.000549	0.00601	CcSEcCtD
Olmesartan—ABCC2—adrenal gland—hypothyroidism	0.000546	0.0422	CbGeAlD
Olmesartan—ABCC2—blood—hypothyroidism	0.000546	0.0422	CbGeAlD
Olmesartan—Shock—Liotrix—hypothyroidism	0.000544	0.00595	CcSEcCtD
Olmesartan—Tachycardia—Liotrix—hypothyroidism	0.000539	0.0059	CcSEcCtD
Olmesartan—Asthenia—Levothyroxine—hypothyroidism	0.000539	0.0059	CcSEcCtD
Olmesartan—Asthenia—Dextrothyroxine—hypothyroidism	0.000539	0.0059	CcSEcCtD
Olmesartan—Hyperhidrosis—Liotrix—hypothyroidism	0.000534	0.00585	CcSEcCtD
Olmesartan—Pruritus—Dextrothyroxine—hypothyroidism	0.000531	0.00582	CcSEcCtD
Olmesartan—Pruritus—Levothyroxine—hypothyroidism	0.000531	0.00582	CcSEcCtD
Olmesartan—Anorexia—Liotrix—hypothyroidism	0.000527	0.00577	CcSEcCtD
Olmesartan—Hypotension—Liotrix—hypothyroidism	0.000516	0.00565	CcSEcCtD
Olmesartan—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000514	0.00563	CcSEcCtD
Olmesartan—Diarrhoea—Levothyroxine—hypothyroidism	0.000514	0.00563	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000503	0.00551	CcSEcCtD
Olmesartan—Insomnia—Liotrix—hypothyroidism	0.0005	0.00547	CcSEcCtD
Olmesartan—Decreased appetite—Liotrix—hypothyroidism	0.00048	0.00526	CcSEcCtD
Olmesartan—Vomiting—Dextrothyroxine—hypothyroidism	0.000478	0.00523	CcSEcCtD
Olmesartan—Vomiting—Levothyroxine—hypothyroidism	0.000478	0.00523	CcSEcCtD
Olmesartan—Fatigue—Liotrix—hypothyroidism	0.000476	0.00522	CcSEcCtD
Olmesartan—Rash—Levothyroxine—hypothyroidism	0.000474	0.00519	CcSEcCtD
Olmesartan—Rash—Dextrothyroxine—hypothyroidism	0.000474	0.00519	CcSEcCtD
Olmesartan—Dermatitis—Levothyroxine—hypothyroidism	0.000473	0.00518	CcSEcCtD
Olmesartan—Dermatitis—Dextrothyroxine—hypothyroidism	0.000473	0.00518	CcSEcCtD
Olmesartan—Constipation—Liotrix—hypothyroidism	0.000472	0.00517	CcSEcCtD
Olmesartan—Headache—Levothyroxine—hypothyroidism	0.00047	0.00515	CcSEcCtD
Olmesartan—Headache—Dextrothyroxine—hypothyroidism	0.00047	0.00515	CcSEcCtD
Olmesartan—Feeling abnormal—Liotrix—hypothyroidism	0.000455	0.00498	CcSEcCtD
Olmesartan—Gastrointestinal pain—Liotrix—hypothyroidism	0.000452	0.00495	CcSEcCtD
Olmesartan—ABCC2—testis—hypothyroidism	0.000452	0.0349	CbGeAlD
Olmesartan—Nausea—Levothyroxine—hypothyroidism	0.000446	0.00488	CcSEcCtD
Olmesartan—Nausea—Dextrothyroxine—hypothyroidism	0.000446	0.00488	CcSEcCtD
Olmesartan—Urticaria—Liotrix—hypothyroidism	0.000439	0.00481	CcSEcCtD
Olmesartan—Abdominal pain—Liotrix—hypothyroidism	0.000437	0.00478	CcSEcCtD
Olmesartan—Body temperature increased—Liotrix—hypothyroidism	0.000437	0.00478	CcSEcCtD
Olmesartan—ABCC2—liver—hypothyroidism	0.000427	0.033	CbGeAlD
Olmesartan—Asthenia—Liotrix—hypothyroidism	0.000396	0.00434	CcSEcCtD
Olmesartan—Pruritus—Liotrix—hypothyroidism	0.000391	0.00428	CcSEcCtD
Olmesartan—AGTR1—Peptide GPCRs—TSHR—hypothyroidism	0.000385	0.0398	CbGpPWpGaD
Olmesartan—Diarrhoea—Liotrix—hypothyroidism	0.000378	0.00414	CcSEcCtD
Olmesartan—Dizziness—Liotrix—hypothyroidism	0.000365	0.004	CcSEcCtD
Olmesartan—Vomiting—Liotrix—hypothyroidism	0.000351	0.00385	CcSEcCtD
Olmesartan—Rash—Liotrix—hypothyroidism	0.000348	0.00381	CcSEcCtD
Olmesartan—Dermatitis—Liotrix—hypothyroidism	0.000348	0.00381	CcSEcCtD
Olmesartan—Headache—Liotrix—hypothyroidism	0.000346	0.00379	CcSEcCtD
Olmesartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000338	0.0348	CbGpPWpGaD
Olmesartan—Nausea—Liotrix—hypothyroidism	0.000328	0.00359	CcSEcCtD
Olmesartan—ABCC2—NRF2 pathway—SLC5A7—hypothyroidism	0.000261	0.027	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00023	0.0238	CbGpPWpGaD
Olmesartan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000227	0.0234	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—TRH—hypothyroidism	0.000206	0.0212	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.000203	0.021	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000191	0.0197	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000184	0.019	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000155	0.016	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000136	0.0141	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000128	0.0132	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000121	0.0125	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000121	0.0125	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000117	0.0121	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—AVP—hypothyroidism	0.000108	0.0112	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.000107	0.011	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—SLC5A5—hypothyroidism	0.000104	0.0108	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—TRH—hypothyroidism	0.000104	0.0107	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	9.7e-05	0.01	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	9.67e-05	0.00998	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—TSHB—hypothyroidism	9.25e-05	0.00955	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—TSHR—hypothyroidism	9.25e-05	0.00955	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	9.21e-05	0.0095	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	8.37e-05	0.00864	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—IYD—hypothyroidism	7.91e-05	0.00816	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.86e-05	0.00812	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—AVP—hypothyroidism	7.25e-05	0.00748	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	7.16e-05	0.00739	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—POMC—hypothyroidism	7.09e-05	0.00732	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	6.94e-05	0.00716	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ATP5O—hypothyroidism	6.72e-05	0.00694	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	6.52e-05	0.00673	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—TPO—hypothyroidism	6.32e-05	0.00653	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	6.18e-05	0.00639	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—TRH—hypothyroidism	5.87e-05	0.00606	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.86e-05	0.00605	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—AVP—hypothyroidism	5.45e-05	0.00563	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—TRH—hypothyroidism	5.33e-05	0.0055	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—IYD—hypothyroidism	5.31e-05	0.00549	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—TSHB—hypothyroidism	5.23e-05	0.0054	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—TSHR—hypothyroidism	5.23e-05	0.0054	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—AVP—hypothyroidism	4.87e-05	0.00503	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.76e-05	0.00491	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—TSHB—hypothyroidism	4.75e-05	0.0049	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—TSHR—hypothyroidism	4.75e-05	0.0049	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.68e-05	0.00483	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ATP5O—hypothyroidism	4.52e-05	0.00466	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TPO—hypothyroidism	4.25e-05	0.00439	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.94e-05	0.00406	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—AVP—hypothyroidism	3.68e-05	0.0038	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CLTC—hypothyroidism	3.64e-05	0.00376	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—POMC—hypothyroidism	3.62e-05	0.00374	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.35e-05	0.00345	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—VAV3—hypothyroidism	3.2e-05	0.0033	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TRH—hypothyroidism	3.15e-05	0.00325	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.14e-05	0.00324	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AVP—hypothyroidism	3.08e-05	0.00318	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—TSHB—hypothyroidism	2.93e-05	0.00302	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—VAV3—hypothyroidism	2.9e-05	0.003	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TSHB—hypothyroidism	2.8e-05	0.0029	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TSHR—hypothyroidism	2.8e-05	0.0029	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AVP—hypothyroidism	2.8e-05	0.00289	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—AVP—hypothyroidism	2.63e-05	0.00272	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3C2A—hypothyroidism	2.61e-05	0.00269	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.57e-05	0.00266	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SH2B3—hypothyroidism	2.5e-05	0.00258	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.47e-05	0.00255	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SLC5A5—hypothyroidism	2.19e-05	0.00226	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—POMC—hypothyroidism	2.05e-05	0.00211	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—TSHB—hypothyroidism	1.97e-05	0.00203	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—POMC—hypothyroidism	1.86e-05	0.00192	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRL—hypothyroidism	1.85e-05	0.00191	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3C2A—hypothyroidism	1.75e-05	0.00181	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.73e-05	0.00179	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VAV3—hypothyroidism	1.72e-05	0.00177	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AVP—hypothyroidism	1.65e-05	0.00171	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC5A5—hypothyroidism	1.47e-05	0.00152	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—POMC—hypothyroidism	1.15e-05	0.00118	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—POMC—hypothyroidism	1.1e-05	0.00113	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1—hypothyroidism	1.06e-05	0.00109	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—POMC—hypothyroidism	7.7e-06	0.000795	CbGpPWpGaD
